Case Report: MSS colorectal extrahepatic (non-liver) metastases as the dominant population for immunotherapy combined with multi-target tyrosine kinase inhibitors

Case Report: MSS colorectal extrahepatic (non-liver) metastases as the dominant population for immunotherapy combined with multi-target tyrosine kinase inhibitors

BackgroundThe microsatellite stability(MSS) subtype of Colorectal Cancer(CRC) represents approximately 95% of mCRC cases. Immunotherapy was not as encouraging as the data for MSS mCRC cancer. We report the treatment of a series of patients with extrahepatic metastasis of MSS colorectal cancer, which...

Full description

Bibliographic Details
Main Authors: Jiayin Liu, Dan Li, Jing Han, Yin Zhang, Xue Zhang, Zhisong Fan, Li Feng, Long Wang, Hui Jin, Jing Zuo, Yudong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
MSS
extrahepatic (non-liver) metastases
dominant population
immunotherapy combined
multi-target tyrosine kinase inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1091669/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1091669/full

Similar Items